19 June 2013
Keywords: gsk, submits, final, data, fda, cervarix, bla
Article | 02 April 2009
UK drug major GlaxoSmithKline has submitted final data from a Phase III pivotal study of cervical cancer vaccine Cervarix to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2009
© 2013 thepharmaletter.com